MedPath

SpO2 Hypoxia Accuracy Validation Study

Completed
Conditions
Hypoxia
Interventions
Other: Pulse Oximeter
Registration Number
NCT03348189
Lead Sponsor
Nonin Medical, Inc
Brief Summary

The primary objective of this study is to evaluate the % oxygen saturation by pulse oximetry accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system during non-motion conditions.

Detailed Description

The primary objective of this study is to evaluate the %SpO2 accuracy of a combined pulse oximetry system which consists of a Nonin sensor ), an adaptor cable, and an oximetry system during non-motion conditions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • The subject is male or female
  • The subject is of any racial or ethnic group
  • The subject is ≥ 30 kg (≥ 66 pounds) in weight (self-reported)
  • The subject has at least one finger height of 0.2 - 1.0 inch (based on measurement)
  • The subject is between 18 years and 50 years of age (self-reported)
  • The subject shows no evidence of medical problems as indicated by satisfactory completion of the health assessment form
  • The subject has given written informed consent to participate in the study
  • The subject is both willing and able to comply with study procedures.
Exclusion Criteria
  • The subject has a BMI greater than 31 (based on weight and height)
  • The subject has had any relevant injury at the sensor location site (self-reported)
  • The subject has deformities or abnormalities that may prevent proper application of the device under test (based on examination)
  • The subject is current smoker (self-reported)
  • The subject has a known respiratory condition (self-reported)
  • The subject has a known heart or cardiovascular condition (self-reported)
  • The subject is currently pregnant, is actively trying to get pregnant, or who has a positive urine pregnancy test on the day of the study
  • The subject has a clotting disorder (self-reported)
  • The subject has Raynaud's Disease (self-reported)
  • The subject is known to have a hemoglobinopathy (self-reported)
  • The subject is on blood thinners or medication with aspirin (self-reported)
  • The subject has unacceptable collateral circulation from the ulnar artery (based on examination)
  • The subject is unwilling or unable to provide written informed consent to participate in the study
  • The subject is unwilling or unable to comply with the study procedures
  • The subject has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ObservationalPulse OximeterHealthy males and females
Primary Outcome Measures
NameTimeMethod
SpO2 Hypoxia Accuracy Validation StudyThrough study completion, 3 months average

Values from the test device will be compared to the values from co-oximetry to determine accuracy of the test device.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinimark

🇺🇸

Louisville, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath